Ocular Tumors and Proton Therapy

Specialist input on eye tumors treated with proton and hadron therapy

Specialist input on eye tumors treated with proton and hadron therapy, including uveal melanoma, drawing on decades of work with dedicated ocular facilities such as Centre Antoine Lacassagne in Nice.

Key Facts

  • Centre Antoine Lacassagne in Nice has treated over 6,600 ocular cases by 2020, about 80% uveal melanoma

  • Proton therapy for uveal melanoma achieves local control rates above 95% at five years

  • Prof. Sauerwein's group in Essen has collaborated directly with the Nice proton therapy programme

Need expert guidance on a similar question?

Talk to our team